PRESCRIPTION PATTERNS OF TUMOUR NECROSIS FACTOR INHIBITOR AND USTEKINUMAB IN PSORIATIC ARTHRITIS: A NORDIC POPULATION-BASED COHORT STUDY

被引：0
|
作者：
Jorgensen, T. S. [1 ]
Dreyer, L. [1 ]
Gudbjornsson, B. [2 ]
Hetland, M. L. [1 ]
Glintborg, B. [1 ]
Askling, J. [3 ]
Chatzidionysiou, K. [3 ]
Di Giuseppe, D. [3 ]
Jacobsson, L. [3 ]
Wallman, J. K. [3 ]
Kristianslund, E. K. [4 ]
Olsen, I. C. [4 ]
Fagerli, K. [4 ]
Lie, E. [4 ]
Nordstrom, D. [5 ]
Aaltonen, K. [5 ]
Joensuu, J. [5 ]
Love, T. J. [2 ]
Geirsson, A. J. [2 ]
Kristensen, L. E. [1 ]
机构：
[1] DANBIO Registry, Copenhagen, Denmark
[2] ICEBIO Registry, Reykjavik, Iceland
[3] SRQ Registry, Stockholm, Sweden
[4] NOR DMARD Registry, Oslo, Norway
[5] ROB FIN Registry, Helsinki, Finland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.4690
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0518
引用
收藏
页码：686 / 686
页数：1
相关论文
共 50 条
  • [1] THE IMPACT OF COMORBIDITIES ON EFFECT AND DISCONTINUATION OF TUMOUR NECROSIS FACTOR INHIBITOR THERAPY IN PSORIATIC ARTHRITIS: A POPULATION-BASED COHORT STUDY
    Ballegaard, C.
    Hojgaard, P.
    Dreyer, L.
    Cordtz, R.
    Jorgensen, T. S.
    Skougaard, M.
    Tarp, S.
    Kristensen, L. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 96 - 96
  • [2] FATIGUE REMAINS A DOMINATNG SYMPTOM DESPITE TUMOUR NECROSIS FACTOR INHIBITOR THERAPY IN PSORIATIC ARTHRITIS: A POPULATION-BASED COHORT STUDY
    Jorgensen, T. S.
    Skougaard, M.
    Ballegaard, C.
    Mease, P.
    Strand, V.
    Dreyer, L.
    Kristensen, L. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 384 - 385
  • [3] Impact of Comorbidities on Tumor Necrosis Factor Inhibitor Therapy in Psoriatic Arthritis: A Population-Based Cohort Study
    Ballegaard, Christine
    Hojgaard, Pil
    Dreyer, Lene
    Cordtz, Rene
    Jorgensen, Tanja Schjodt
    Skougaard, Marie
    Tarp, Simon
    Kristensen, Lars Erik
    [J]. ARTHRITIS CARE & RESEARCH, 2018, 70 (04) : 592 - 599
  • [4] Relation Between Fatigue and ACR Response in Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitor Therapy: A Population-based Cohort Study
    Jorgensen, Tanja Schjodt
    Skougaard, Marie
    Hansen, Rebekka Lund
    Ballegaard, Christine
    Mease, Philip
    Strand, Vibeke
    Dreyer, Lene
    Kristensen, Lars Erik
    [J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (06) : 829 - 835
  • [5] Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study
    Michielsens, Celia A. J.
    den Broeder, Nathan
    Mulder, Michelle L. M.
    van den Hoogen, Frank H. J.
    Verhoef, Lise M.
    den Broeder, Alfons A.
    [J]. RHEUMATOLOGY, 2022, 61 (06) : 2307 - 2315
  • [6] RISK OF NEUROLOGICAL ADVERSE EVENTS DURING TUMOUR NECROSIS FACTOR INHIBITOR TREATMENT FOR ARTHRITIS: A POPULATION-BASED COHORT STUDY FROM DANBIO AND ARTIS
    Kopp, Tine Iskov
    Arkema, Elizabeth
    Cordtz, Rene
    Delcoigne, Benedicte
    Askling, Johan
    Dreyer, Lene
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 211 - 211
  • [7] Secular Trends in Treatment Patterns for Psoriasis and Psoriatic Arthritis: A Population-Based Cohort Study
    Merola, Joseph F.
    Lii, Joyce
    Desai, Rishi J.
    Solomon, Daniel H.
    Kim, Seoyoung C.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [8] Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis
    Stober, Carmel
    Ye, Weiyu
    Guruparan, Thushyanthan
    Htut, Eiphyu
    Clunie, Gavin
    Jadon, Deepak
    [J]. RHEUMATOLOGY, 2018, 57 (01) : 158 - 163
  • [9] Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study
    Kristensen, Lars Erik
    Englund, Martin
    Neovius, Martin
    Askling, Johan
    Jacobsson, Lennart T. H.
    Petersson, Ingemar F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (10) : 1675 - 1679
  • [10] Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study
    Hansen, Rebekka Lund
    Jorgensen, Tanja Schoedt
    Dreyer, Lene
    Hetland, Merete L.
    Glintborg, Bente
    Askling, Johan
    Di Giuseppe, Daniela
    Jacobsson, Lennart T. H.
    Wallman, Johan K.
    Nordstrom, Dan
    Aaltonen, Kalle
    Kristianslund, Eirik K.
    Kvien, Tore K.
    Provan, Sella A.
    Gudbjornsson, Bjorn
    Love, Thorvadur J.
    Kristensen, L. E.
    [J]. RHEUMATOLOGY, 2021, 60 (01) : 140 - 146
12345